ArticleBMC public health2025
Current status of pharmacists in community pharmacies in China in the health management of chronic respiratory diseases.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Air pollution and respiratory health: a multinational needs assessment of physicians.ERJ open research · 2026Article
- Article
- Exploring community pharmacy manager/ pharmacist perceptions and responses to China's dual-channel policy for improving access and rational use of innovative drugs: a qualitative study.International journal of clinical pharmacy · 2025Article
- Chronic disease management: policy design based on service design methods.Frontiers in public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundEffective management of chronic respiratory diseases (CRDs) is critical, and community pharmacists play a key role. This study evaluates pharmacists' knowledge, attitude, technology use and patient education in CRDs management across various regions in China.
methodsThis cross-sectional study conducted a survey of pharmacists across nine provinces and two municipalities in China from January to September 2024, using a stratified convenience sampling method based on regional GDP. A total of 733 questionnaires were distributed through online platforms and pharmacy networks, yielding 699 valid responses, resulting in a response rate of 95.4%.
results61.5% of pharmacists correctly answering 5 or fewer questions on knowledge-related topics. Additionally, 68.1% of the pharmacists demonstrated an accuracy rate of less than 50% in COPD-related questions, and 58.7% had an accuracy rate below 50% in asthma-related questions. Pharmacists in developed regions showed higher scores in knowledge, attitude, and patient education compared to those in underdeveloped areas (P < 0.05). Higher education and professional certifications were associated with better scores (P < 0.05). Frequent CRDs patient management and positive attitudes enhanced technology use, while longer working hours were linked to lower technology use and patient education scores (P < 0.05). Higher knowledge and attitude scores were significantly associated with better patient education (P < 0.05).
conclusionCommunity pharmacists display significant knowledge gaps in managing CRDs, particularly COPD and asthma. Developed regions, higher education, certification, and frequent CRDs management correlate with better scores. These findings highlight the need for ongoing education and improved working conditions to strengthen pharmacists' roles in CRDs management, aligning with the Healthy China initiative.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.